Home Atalanta Therapeutics

Atalanta Therapeutics

In operation
Series B
Biological New Drug Developer
Basic
Enterprise Profile

Basic Information

Atalanta Therapeutics was founded to address the urgent global need for interventions to treat neurodegenerative diseases. The groundbreaking discoveries of our founders in RNA interference provide a powerful therapeutic approach to halt diseases at their source.
Atalanta Therapeutics, Inc.
Boston,Massachusetts,United States of America
15~50 people
January 01, 2018
contact@atalantatx.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Concept
Disease Treatment # Nervous System Diseases
Application Scenarios
Innovative Drugs